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Secondary amyloidosis is a  condition characterized by the deposition  of an 
extracellular fibrillar protein, amyloid protein A  (AA), 1 which may lead to the 
failure of vital organ functions. As a  rule, this type of amyloidosis develops in 
response to chronic stimuli associated with infectious, inflammatory, or neoplastic 
diseases.  In some instances, e.g., familial Mediterranean fever, the etiology of 
the inflammatory condition is obscure, but amyloidosis develops in a very high 
percentage, if not all, of the affected patients (1). 
The AA protein (8,000 mol wt) is believed to be derived from the acute phase 
reactant, serum amyloid A (SAA) (12,500 mol wt), by proteolytic cleavage of its 
carboxy terminus (2-4). A series of studies designed to identify the cells involved 
in  SAA  degradation  have  shown  that  proteinases associated  with  the plasma 
membrane  of peripheral  blood  monocytes can  mediate  this  function  (5-7). 
Mononuclear leukocytes of most healthy individuals degraded SAA completely, 
whereas the cells of patients with amyloidosis yielded an intermediate product 
that had electrophoretic mobility and immunological crossreactivity with AA (5). 
This  observation  led  to  the  hypothesis  that  the  deposition  of AA  might  be 
attributable to faulty processing of SAA, especially since SAA attains very high 
serum levels in patients with conditions prone to the development ofamyloidosis. 
In line with this postulate,  it seemed appropriate  to investigate whether fixed 
macrophages are involved in the catabolism of SAA. In fact, cells of the reticu- 
loendothelial system have long been implicated in amyloidosis (8-13).  Kupffer 
cells (KC),  in  particular,  have been held responsible for amyloid synthesis and 
deposition  in  the liver (10,  11),  and the literature is replete with illustrations 
showing the relationship of AA fibrils to the plasma membrane of these cells 
(12). The existence of a thoroughly studied animal model for secondary amyloi- 
dosis (14,  15) has provided us with the opportunity to investigate whether KC, 
isolated from animals with experimentally induced amyloidosis, have the same 
defect in  the proteolysis of SAA as peripheral blood  mononuclear leukocytes 
obtained  from  patients  afflicted  with  this  condition.  Accordingly,  KC  were 
isolated from the livers of normal mice and of mice sacrificed at various time 
intervals during the induction of amyloidosis with casein. The cells were cultured 
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with  SAA and  their  ability to  degrade  this  protein  was determined  by sodium 
dodecyt  sulfate-polyacrylamide gel electrophoresis  (SDS-PAGE) of the  culture 
media.  KC of healthy animals degraded SAA completely, whereas supernatants 
of KC obtained from animals with amyloidosis revealed not only residual SAA, 
but also an intermediate product indistinguishable  from AA. Even more signifi- 
cantly, the  AA product  was found  in  KC cultures  prepared from animals that 
had  received  few  injections  of casein,  i.e.,  before  amyloid  deposits  could  be 
demonstrated  by  Congo  Red  staining  or  electron  microscopy  of their  intact 
organs. The addition to these cultures of KC from healthy animals led to complete 
degradation of the AA intermediate product. Thus, altered KC function appears 
to  precede  deposition  of  fibrillar  amyloid.  The  observations  leading  to  this 
conclusion are the subject of this communication. 
Materials and  Methods 
Preparation of Animals  and Tissues.  Animals were male, 4-5-mo-old C57BL]6J mice 
(The Jackson  Laboratory,  Bar  Harbor,  ME)  weighing  _>30 g  at the  beginning  of the 
experiments. They were housed in groups of five or six per cage, fed Purina mouse chow, 
and given water ad libitum. Each animal received daily subcutaneous injections of 0.5 ml 
of 10% casein (Fisher Scientific Co., Pittsburgh, PA) in 0.5 M sodium bicarbonate. Control 
animals received no  treatment.  Tissues and  cells  were prepared  from groups of mice 
sacrificed after having received 0, 8,  13,  18,  20, and >30 injections. The spleens, livers, 
and  kidneys from representative animals of each  group  were processed for light  and 
electron microscopy. Frozen and embedded tissues were stained by the alkaline Congo 
Red method (16)  for the detection  of amyloid. Samples for electron  microscopy were 
fixed in 3% glutaraldehyde, postfixed in osmium tetroxide, stained en bloc with uranyl 
acetate, dehydrated,  and embedded in  Poly/Bed 812.  Thin sections, obtained with an 
LKB ultratome (LKB Instruments,  Inc.,  Gaithersburg,  MD),  were stained  with  uranyl 
acetate and lead citrate and viewed with a Siemens Elmiskop I electron microscope. 
Isolation of KC.  Mice were anesthetized by intraperitoneal injection of sodium pento- 
barbital (Nembutal; Abbott Laboratories, Irving, TX) in saline 5 mg/ml (0.06  mg/g of 
body weight). The perfusion-isolation procedure was modified from a procedure devised 
by us for the isolation of KC from rats (17).  Briefly, the portal vein was cannulated with 
a 21 gauge needle connected with plastic tubing to the perfusate container. The perfusate 
was kept at 37°C. A syringe equipped with a Millipore filter (Millipore Corp., Bedford, 
MA) was inserted between the container holding the perfusate and the tubing leading to 
the  portal  vein.  The  flow  rate  was  maintained  at  2  ml/min  with  a  peristaltic  pump 
(Scientific Industries, Inc., Bohemia, NY). After perfusion was established, the thorax was 
opened and the inferior vena cava was cut to permit the perfusate to drain. Perfusion was 
initiated for 8-10 min with Dulbecco's modified Eagle's medium (DME), containing 4.5 
mg glucose per milliliter, 2% heat-inactivated fetal calf serum, and 0.2% heparin (1,000 
U/ml), penicillin,  and streptomycin. This was followed by 10  rain of enzyme perfusion 
consisting of the same medium to which had been added 0.1% collagenase type IV (260 
U/mg; Sigma Chemical Co., St.  Louis, MO), 0.2% pronase (70,000 PUK/g; Calbiochem- 
Behring Corp., La Jolla, CA), 5 mM CaC12, and 0.8 mg% deoxyribonuclease. The entire 
procedure was carried out under sterile conditions. At the end of the perfusion, the liver 
became soft. It was excised quickly and transferred to a sterile petri dish containing cold 
culture  medium.  The  gall  bladder  was  removed and  the  remaining liver pieces  were 
transferred to another petri dish containing the same enzyme solution. With the help of 
two pointed forceps, the organ was then completely disrupted. The cell suspension and 
remaining pieces of tissue were transferred to a 75 cm  2 tissue culture flask containing 50 
ml of the same enzyme solution. This suspension was agitated for 60 min on a rocker kept 
in  a  37°C  incubator  with  5%  COz and  100%  humidity.  At the end of the  incubation 
period, the cell suspension was passed through a two-layer gauze into a 30 ml plastic test FUKS  AND  ZUCKER-FRANKLIN  1015 
tube, which was then centrifuged at 1,200 rpm for 5 min. The pellet was resuspended in 
35 ml DME, placed on a  17 ml FicolI-Hypaque gradient prepared as described (18),  and 
centrifuged at 400 g  for 30 rain at room temperature. The ceils at the interface were 
washed  twice,  resuspended,  and  counted.  Cell  viability  was  checked  by  trypan  blue 
exclusion and phagocytosis of latex particles. Without exception, the cells used in these 
experiments were >95% viable and phagocytic. 
KC Cultures.  The isolated washed cells were plated at a concentration of 7 ×  106/ml 
on  35-ram petri dishes (Falcon Labware, Oxnard,  CA) and  incubated at 37°C  in  10% 
CO2 and  100%  humidity.  After 24 h,  the supernatant containing unattached cells and 
debris were removed and the medium was replaced with fresh DME containing 10% fetal 
calf serum. In some instances, sterile glass coverslips were placed into the plastic culture 
dishes to permit KC attachment to glass which is necessary for Congo Red staining and 
other histochemical procedures. 
Incubation  of KC with SAA.  After 48 h  in culture, the serum-containing medium was 
washed from adherent KC and replaced with  1 ml of serum-free DME, to which 200 ttg 
SAA had been added. On some occasions, the KC were scraped off the culture dish and 
incubated with the SAA-containing medium in suspension. The preparation of SAA has 
been described in detail (19). Supernatants of KC incubated with or without SAA were 
collected at 0, 4, 8, and 18 h. Each specimen was dialyzed against distilled H~O for 24 h. 
After lyophilization, the samples were placed on  10-20%  SDS-polyacrylamide slab gels 
(20).  Cytochrome c (13,000  mol wt) was used as a  marker. The gels were stained with 
Coomassie Blue and the products of enzymatic digestion were quantitated at 516 nm with 
a Guilford 250  spectrophotometer equipped with a scanner and recorder.  Values were 
expressed as the percentage of residual SAA or AA after incubation with KC. 
The culture medium of control KC was also incubated with SAA to determine whether 
the relevant proteolytic activity is secreted or whether,  as in  the case of monocytes, it 
remains intimately associated with cells.  In addition, the KC as well as the medium were 
incubated separately with orcein-impregnated elastin (Sigma Chemical Co.) to assay for 
elastase-like enzymes as described previously (21, 22). 
Electron Microscopy and Histochemistry of Cultured KC.  Samples of control KC and KC 
incubated with SAA obtained from each group of animals were fixed in situ overnight 
with  3%  phosphate-buffered glutaraldehyde.  All  specimens were dehydrated  and  flat- 
embedded in Poly/Bed 812 as described in detail (23). The cells were sectioned mostly at 
right angles to the surface that was attached to the substrate.  Electron microscopy was 
carried out as described for tissues. 
Light microscopy and histochemistry was usually performed on cells attached to the 
glass  coverslips that  had  been  placed  in  the  culture  dishes.  These  were  stained  with 
Wright's and Giemsa, alkaline Congo Red (16), and examined for the presence of acid 
pbosphatase, peroxidase (24), a-naphthyl acetate esterase (25), and glucose-6-phosphate 
dehydrogenase (26). 
Results 
Under the conditions of our protocol, amyloid deposition could not be detected 
in the  livers, spleens, or kidneys of animals that had received <18  injections of 
casein.  Only two of the mice that had been injected  18 times revealed traces of 
Congo  Red-positive  material  in  their  kidneys.  No amyloid deposits  were ever 
found,  even  upon  electron  microscopy  of tissues  prepared  from  animals  that 
received  13 or fewer injections of the antigen. 
The  yield of purified  KC obtained  from healthy  animals was  1.5-2.0  x  10 7 
per  liver.  The  cells were >95%  viable and  phagocytic.  Their  KC identity  was 
established unequivocally by ultrastructural and histochemical analyses. The cells 
were strongly positive for glucose-6-phosphate dehydrogenase,  an enzyme that 
is only weakly expressed by endothelial cells (26). The likelihood that they were 1016  IMPAIRED  KUPFFER  CELL  FUNCTION  PRECEDES  AMYLOIDOSIS 
contaminated by fibroblasts was ruled out by our observation that fibroblasts are 
killed by pronase (unpublished results). Since the KC of unstimulated mice were 
only loosely attached after 18 b of incubation, experiments on the degradation 
of SAA were begun after 48 h. As illustrated in Fig. 1, the morphology of normal 
KC was fairly homogeneous. Although there was some spreading, the majority 
of control  cells  remained  spindle-shaped,  exhibited oval nuclei,  and  had  few 
inclusions.  During  the  course  of amyloid induction,  there  was  a  progressive 
increase in the number of cells harvested per liver as well as a remarkable change 
in their morphology. KC obtained from mice that had received as few as eight 
subcutaneous injections of casein already showed physiologic and morphologic 
changes. Attachment and spreading took place within a few hours. There was a 
decrease in the nucleocytoplasmic ratio, an increase in the number of inclusions 
and vacuoles, and, in general, the cytoplasm had developed the "busy" appearance 
of stimulated macrophages (27).  As expected, there was a  marked increase in 
acid  phosphatase.  However,  the  content of some  lysosomal enzymes had  de- 
creased.  As seen  in  Fig.  2,  the  number of KC harvested from mice with  18 
injections had  doubled;  in  mice  receiving 30  injections, there  was a  fivefold 
increase  in  the  yield.  When  the  livers  had  become  grossly amyloidotic, the 
morphology of the  cells  isolated  as  KC  was  very  heterogeneous.  There  was 
contamination  with  monocytes,  lymphocytes,  and,  occasionally,  neutrophils. 
Since this was not the case in animals that bad received <18 injections of casein, 
nor before amyloid was grossly evident, the heterogeneity of the cell population 
harvested from amyloidotic livers was not considered relevant to the aim of these 
studies. 
Degradation  of SAA  by  KC.  KC  isolated  from  healthy,  unstimulated  mice 
degraded SAA completely without the appearance of the intermediate cleavage 
product, protein  AA.  After 4  h  of incubation, the concentration of SAA was 
reduced to 33.0  +  5.4%  of the original amount of SAA added (Figs.  3 and 4). 
KC of mice injected eight times with casein showed 50.0  +__  3.28%  remaining 
SAA after 4 h of culture. When supernatants of these cells were analyzed after 
8 and 18 h of culture, the residual SAA proved to be  18.0 +  2.44% and 16.5 + 
3.36%, respectively. More importantly, a band corresponding to the AA protein 
bad  appeared  that  was  digested  on  overnight  incubation  (Fig.  3).  KC  from 
animals that had received 13 injections were able to degrade only 31.5 +  4.20% 
of the protein during the first 4 h, 78.0 _+ 3.33% in 8 h, and 78.0 +-- 2.08% after 
18 h in culture. Moreover, the AA band that represented 19.62 +  1.88% of the 
residual protein at 8  h  and 24.30  +  3.09%  after  18  h  of culture had become 
conspicuous (Fig. 3).  It should be recalled that animals that had received 13 or 
fewer injections of casein did not have amyloidosis, nor could amyloid fibrils be 
demonstrated in their KC cultures to which SAA had been added (see below). It 
is thus likely that the AA cleavage product found in the culture medium had not 
yet polymerized into insoluble amyloid fibrils. KC obtained from mice with  18 
or more injections of casein revealed an even greater impairment in their ability 
to degrade SAA. As seen in Figs.  3 and 4,  KC of mice with  18  injections had 
processed only ~1/3 of the substrate SAA on overnight incubation, and a distinct 
AA band became visible on SDS-PAGE of the 8-h culture medium. This was not 
degraded  by  the  cells  even  after  incubation  for  18  h.  Quantification of the FUKS  AND  ZUCKER-FRANKLIN  1017 
FIGURE  |.  (a)  KC isolated from a  normal, unstimulated mouse, cultured overnight as de- 
scribed in text. Stained with Wright's and Giemsa. (b) KC isolated from the liver of a mouse 
that had been stimulated with casein. Note that the cells have become heterogeneous in size 
and shape. They display numerous vacuoles and inclusions. There is some admixture with 
smaller cells (arrows) that have the appearance of lymphocytes or undifferentiated stem cells. 1018  IMPAIRED  KUPFFER  CELL  FUNCTION  PRECEDES  AMYLO1DOSIS 
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FIC;URE 2.  Effect of casein treatment on the yield of KC. There appears to be a progressive 
increase in the number of cells harvested per liver. Bars,  _+SD. 
FIGURE 3.  SDS-PAGE patterns  with supernatants  of  KC  cultures.  The  KC  were  isolated 
from the livers of mice that had received  0,  8,  13, or  18 injections of casein. The cells were 
incubated with SAA for 4  h, 8  h, and overnight  (O/N).  Control shows the two SAA isotypes 
characteristic for mice. Arrow indicates AA band. Stained with Coomassie Blue. 
amount  of  residual  SAA  and  AA  in  supernatants  of  KC  cultures  is  shown 
graphically  in  Fig.  4.  It  is obvious  that  there  was an  ever-increasing  amount  of 
residual  SAA  as  well  as  larger  quantities  of AA  during  the  course  of amyloid 
induction. 
To determine whether the presence of intact KC was a requirement or whether 
enzymes  secreted into the medium could also mediate  SAA  degradation,  super- 
natants of control and stimulated KC were used as a source of enzymatic activity. 
As  seen  in  Fig.  5,  neither  the  supernatant  of  normal  KC  cultures  nor  the 
supernatants  of stimulated  KC could degrade  SAA,  indicating  that the enzymes 
responsible  for SAA  hydrolysis are cell-associated  as had been shown previously 
to be  the  case  for blood  monocytes  (6,  7).  On  the  other  hand,  supernatants  of 
normal  and  stimulated  KC  degraded  elastin-orcein,  indicating  that  some  elas- 
tase(s) were secreted by the cells into the medium (data not shown). 
Reversibility of Processing Defect.  In a  few experiments,  normal  KC  harvested 100- 
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FIGURE 4.  Spectrophotometric quantitation of residual SAA and AA in supernatants of KC. 
The cells were derived from mice that had received 0,  8,  13,  18, or 30 injections of casein 
and were incubated for 4, 8, or 18 h with SAA. Larger amounts of residual SAA and increasing 
quantities of AA appeared during the amyloid induction period. When the animals had been 
given more than eight injections of the stimulant, their KC were no longer able to eliminate 
the AA intermediate product. 
FIGURE 5.  SDS-PAGE showing the following: (I) SAA; (2) SAA incubated with supernatant 
of normal KC cultures, showing that the medium does not contain enzymes responsible for 
SAA  degradation;  (3)  SAA  incubated  with  supernatant  of  KC  culture  prepared  from  an 
amyloidotic liver; (4) pattern obtained when SAA was incubated with KC from a  mouse that 
had received 18 injections of casein, showing the AA intermediate product; (5) result obtained 
when  normal  KC  were  added  to  the  supernatant shown  in  lane  4.  The  intermediate  AA 
fragment was eliminated. 
from control animals were added to medium derived from KC cultures that had 
produced the AA intermediate product. To this end, 2 ×  108 KC isolated from 
healthy animals were added to  1 ml of supernatant derived from cultures that 
had produced AA, as identified by SDS-PAGE.  The normal KC were able  to 
complete  the  degradation process  within  4  h  (Fig.  5),  suggesting that  faulty 
degradation is not attributable to an aberrant or "indigestible" structure of the 
protein. It should also be noted, when KC obtained from the 25-injection group 
were  cultured  with  SAA  6  wk  after  cessation  of casein  treatments,  the  AA 
intermediate product was seen in 8-h cultures, but it could still be processed on 
overnight incubation. When animals from the 25-injection group were rested 10 
wk, the ability of their KC to degrade SAA to completion within 4 h was restored. 1020  IMPA1RED  KUPFEER CELL  FUNCTION  PRECEDES AMYLOIDOS1S 
On the other hand,  KC from animals that had received 35  casein injections did 
not recover their ability to degrade SAA over a  10 wk period. Whether recovery 
took place  after that  time  of observation  was  not  established,  nor  has  it  been 
determined whether this recovery was due to restored enzyme function of "old" 
cells or if the KC population  had been replenished. 
Fibrillogenesis.  Lastly, it seemed of interest to examine whether impaired KC 
would  also  be  responsible  for  the  polymerization  of soluble  AA,  detected  on 
SDS-PAGE,  into  insoluble  fibrils.  In  this  regard,  it cannot  be stressed  enough 
that  KC  isolated  from  amyloid-laden  livers  could  never  be  freed  entirely  of 
adhering or phagocytosed fibrils (Figs. 6  and 7).  Therefore, such specimens can 
probably not  be  used  to  distinguish  whether  the  fibrils  had  formed in  vivo or 
whether they were derived from the SAA which had been added in vitro.  Such 
fibrils have the appearance characteristic of amyloid described in detail elsewhere 
(28). They are either located in vacuoles, probably when they have been phago- 
cytosed  (Fig.  6),  or  are  found  in  spaces  delimited  by  membranes  that  are  in 
continuity with the surface (Fig. 7). On only two occasions did a fibrillar substance 
seem  to  have  formed  upon  addition  of SAA  to  cultures  of KC  derived  from 
casein-stimulated mice whose intact organs and control  KC were still devoid of 
amyloid. 
An example of such filaments is illustrated  in  Fig.  8.  Their close proximity to 
FIGURE 6.  (a) KC isolated from an animal that had received 30 injections of casein. The cells 
were washed three times before being plated. No SAA was added to the culture. Despite this, 
the cell exhibits two vacuoles (arrows) containing amyloid fibrils. It is possible that these fibrils 
were taken up by the cell during the isolation procedure,  x  4,000. (b) Detail of the vacuole 
indicated by the rectangle in a showing amyloid fibrils at higher resolution, x 42,000. FUKS  AND  ZUCKER-FRANKLIN  1021 
FIGURE  7.  A  KC from the same specimen as that in Fig. 6. This cell  has been selected to 
illustrate  another  type  of fibril-containing inclusion  seen  in  KC  isolated from  mice  with 
amyloidosis (arrows). These inclusions have an irregular circumference and appear to be in 
continuity with narrow channels and the cell surface. These membrane-bound spaces do not 
resemble phagocytic vacuoles (see text).  A  large  number of lipid bodies (L),  vesicles, and 
granules are characteristic for stimulated KC.  The  inset shows the fibrils of the inclusion 
indicated by the larger arrow at higher resolution. The fibrils are double-stranded, as is typical 
for mature, fully polymerized amyloid. ×  5,000. Inset, ×  120,000. 
the invaginated plasma membrane of the cells is noteworthy. In cross section, 
they measured ~100  A,  while  their  length could  not  be  determined in  thin 
sections. 
Discussion 
During  the  past  decade,  the  cellular  origin  and  biochemical  composition  of 
several  amyloids  have  been  elucidated  (2-5,  28-31),  but  it  is  not  clear  why, 
under some conditions, these proteins are deposited in fibrillar form. In second- 1022  IMPAIRED  KUPFFER  CELL  FUNCTION  PRECEDES  AMYLOIDOSIS 
FIGURE  8.  (O.) Detail  of a  KC  obtained  from  a  mouse that  had  received  18  injections of 
casein.  No  amyloid  could  be  demonstrated  in  the  intact  organs  or  isolated  KC.  The  cell 
illustrated was taken from a specimen of KC cultured with SAA for 18 h. x  19,000. (b) Higher 
magnification of the area delineated by the rectangle in a. Filaments have formed within the 
area  of cellular  invagination  in  close  proximity  to  the  plasma  membrane.  Dots  represent 
filaments in cross section. X 86,000. FUKS  AND  ZUCKER-FRANKLIN  1023 
ary amyloidosis, the congophilic AA fibrils are presumably derived by proteolytic 
cleavage of a normal plasma component, serum amyloid A (SAA) (2-4). SAA is 
synthesized by hepatocytes (32) and may attain very high levels in patients with 
infectious diseases or animals subjected to repeated inflammatory stimuli (14, 
15). However, there is no correlation between the serum levels of SAA and the 
development of amyloidosis (33,  34).  In  fact, colchicine treatment of patients 
with familial Mediterranean fever (35) or of mice subjected to amyloid-inducing 
stimuli (36) prevents amyloidogenesis without reducing the plasma levels of SAA. 
Therefore, overproduction of SAA alone is not responsible for the condition. 
Alternative explanations have been sought. Amyloid formation could be due to 
the  synthesis  of an  aberrant,  incomplete  molecule,  AA,  which  subsequently 
polymerizes into fibrils, or it could be due to improper catabolism of SAA with 
similar results.  Indeed, protein  AA-crossreacting material  has been  found in 
homogenates of livers from casein-stimulated mice before amyloid fibrils could 
be detected (36). However, these experiments were not designed to distinguish 
between faulty synthesis or processing, and did not determine which cell type 
might be involved. 
The first clue that AA formation may be caused by faulty processing of SAA 
was the observation that incubation of SAA with peripheral blood monocytes of 
patients with amyloidosis yielded an intermediate product that had immunologic 
and amino acid sequence identity with AA, whereas monocytes of most healthy 
individuals degraded SAA completely (5).  To demonstrate that impaired catab- 
olism of SAA by the macrophage phagocytic system (MPS) may actually precede 
formation  of amyloid deposits  necessitated the  use  of experimental animals. 
Accordingly, we turned to the well-studied model of murine amyloidosis (14, 51) 
and focused on  KC,  since these cells have been implicated in amyloidogenesis 
for  many decades  (12).  The  results  were clear-cut.  When  KC  isolated  from 
control mice were incubated with SAA, they degraded the peptide completely, 
whereas  KC  obtained  from  amyioidotic  mice  yielded  the  intermediate  AA 
product. Of even greater interest was the observation that impaired KC function 
could be observed before any amyloid was detected in the organs of mice from 
which the KC bad been derived, and whose isolated KC showed no fibrils on 
electron microscopy. The appearance of AA in the cultures was accompanied by 
qualitative and quantitative alterations in the KC (Figs.  1 and 2). They assumed 
the  appearance  of "activated"  macrophages  and  exhibited  an  increase  in  c~- 
naphthyl acetate esterase and a reduction in c~-naphthyl butyrate esterase (data 
not shown, and 37). With increasing numbers of casein injections, progressively 
larger amounts of residual SAA and AA were found in cultures (Fig.  4).  The 
addition  of normal  KC  to  supernatants  of cultures  that  had  produced  AA 
eliminated the peptide (Fig. 5). Therefore, it may be concluded that soluble AA 
per se is not resistant to hydrolysis by normal cells and that the appearance of 
this peptide is due to the inability of the stimulated cells to degrade SAA to 
completion. At first glance, it seemed puzzling that macrophages which appear 
activated would, at the same time, be defective in some degradative functions. 
There  is,  however,  precedent  for  the  observation  that  stimulation  of some 
enzymes  may  be  accompanied  by  down-regulation  of others.  This  may  be 
particularly relevant to the metabolism of ectoenzymes, where down-regulation 1024  IMPAIRED  KUPFFER  CELL  FUNCTION  PRECEDES  AMYLOIDOSIS 
could be attributable  to  internalization  of portions  of the  surface membrane. 
Thus,  it  has  been  shown  that  5'  nucleotidase activity becomes reduced  when 
peritoneal macrophages are stimulated (38, 39), and a decrease in receptors after 
binding and internalization  of ligands has been observed in several systems (e.g., 
40). We have shown for monocytes that degradation of SAA is surface membrane 
associated (5, 7,  22). It is likely that the same holds true for KC, especially since 
SAA  degradation  also  required  the  continuous  presence  of the  cells.  Since 
activated KC are replete with interiorized  material,  it is possible that activated 
KC lose some of their  degradative ability by this  process, i.e.,  that  portions of 
their  plasma membrane become internalized.  This  hypothesis requires  further 
study. 
In any case, the data presented here seem to permit the conclusion that  the 
production  of AA  is  due  to  faulty processing  of SAA.  It  is  still  necessary  to 
explain  by what  mechanism  soluble AA,  detected by SDS-PAGE,  polymerizes 
into fibrils.  It is of interest to mention that  Hoffman et al.  (41) have suggested 
that only one isotype of murine SAA is fibrillogenic. To observe this fibrillogen- 
esis, KC isolated at various stages during amyloid induction were incubated with 
SAA and subjected to electron microscopy. Our studies were hampered by the 
observation that KC isolated from amyloidotic mice could not be entirely liber- 
ated from either phagocytosed or adhering fibrils. This was particularly surpris- 
ing since the method for the isolation of KC included extensive enzyme treat- 
ments,  multiple washes, and cell fractionations.  As explained in the results and 
the  legend  to  Fig.  6,  it  is possible that  some of the  fibrils  were phagocytosed 
during  the  isolation  procedure,  a  process that  has been demonstrated  to take 
place in vitro (42).  However, the configuration  of some of the fibril-containing 
inclusions,  e.g.,  the  ones  illustrated  in  Fig.  7,  did  not  resemble  phagocytic 
vacuoles. The membranes of such inclusions were usually in continuity with the 
plasma membrane.  As mentioned before, SAA degradation  is mediated by cell 
surface enzyme(s).  It is conceivable that  not only AA production,  but also its 
polymerization into fibrils, occurs in intimate contact with the plasma membrane. 
In  considering  the  topology of the  KC  with  its numerous  processes and  deep 
cytoplasmic invaginations,  referred to as worm-like structures  (43; reviewed in 
44),  it  takes  little  imagination  to  conceive how  fibrils  formed  on  the  surface 
membrane and its invaginations could appear as though they were both intracel- 
iular and extracellular.  Proof of this phenomenon would settle the controversy 
over  whether  the  fibrils  go  into  or  come  out  of the  cells.  The  concept  that 
insoluble  filaments  can  be  formed  as  a  result  of crosslinking  of peptides  by 
enzymes  associated  with  plasma  membranes  is  not  novel.  Examples  include 
cytosolic proteins of keratinocytes crosslinked to form a water-insoluble envelope 
(45), and  various cytoskeletai proteins of erythrocytes which,  when crosslinked 
by the cells' transglutamidase(s),  cause irreversible  loss of membrane  deforma- 
bility (46). 
Since  amyloid  fibrils  have  not  yet  been  produced  experimentally  in  vitro, 
nothing is known about the process of polymerization itself, i.e., whether mole- 
cules assemble side to  side,  end  to  end,  or in  any other  way.  Therefore,  it  is 
difficult to interpret  images like the one shown in  Fig.  8.  Since the cells were FUKS AND  ZUCKER-FRANKLIN  1025 
incubated with SAA in a serum-free medium and such filaments were not seen 
in control KC cultures, it is possible that the filaments were derived from SAA. 
Thus, there is accumulating evidence showing that amyloidogenesis of the AA 
type is a  muitistep process. The present studies have clearly demonstrated that 
the elaboration of a soluble AA peptide is due to faulty processing of precursor 
SAA by KC defective in this regard.  Whether KC are also involved in polymer- 
ization of this peptide into insoluble fibrils awaits further proof. 
Summary 
It  has  been  demonstrated  previously  that  the  acute  phase  reactant,  serum 
amyloid  A  (SAA),  is  subject  to  degradation  by surface  membrane-associated 
proteinases of peripheral blood monocytes. However, monocytes obtained from 
the  blood of patients  with  amyloidosis degraded  SAA  incompletely,  leaving a 
cleavage product that,  biochemically and immunologically,  resembled the amy- 
loid protein  A  (AA) deposited in their  tissues. To investigate  the role of fixed 
macrophages in amyloidogenesis and to establish more definitively that amyloid 
deposition  is attributable  to  faulty processing of the  precursor  protein  rather 
than  aberrant  synthesis,  secondary amyloidosis was induced in C57BL/6J mice 
by serial injections of casein. Kupffer cells (KC) were isolated from livers of mice 
that  had  received 0,  8,  13,  18, and >30  injections of the  stimulant.  The  cells 
were  cultured  with  SAA  for  4,  8,  and  18  h  and  then  subjected to  electron 
microscopy and  enzyme analyses.  The  medium was analyzed by SDS-PAGE to 
determine  the  amount  of residual  SAA and/or  the appearance  of AA.  KC of 
healthy  animals  degraded  SAA  completely  whereas  KC  of  stimulated  mice 
showed  increasing  amounts  of residual  SAA  and  the  appearance  of the  AA 
cleavage product.  The  AA peptide  appeared  in  KC cultures  early during  the 
course of casein injections and before any amyloid could be demonstrated in the 
organs of the stimulated  mice. The addition of KC isolated from healthy mice 
to cultures that had produced AA eliminated the abnormal peptide. The results, 
indicate  that  defective  KC  function  precedes amyloidosis.  The  abnormal  AA 
cleavage product formed by such cells is still  susceptible to hydrolysis by normal 
cells. In addition, ultrastructural evidence is presented that suggests that KC may 
also play a role in fibrillogenesis of the AA protein. 
Received for publication  lO January 1985 and in revised form 13 February  1985. 
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